We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Codexis Enters into Research Collaboration with Schering-Plough
News

Codexis Enters into Research Collaboration with Schering-Plough

Codexis Enters into Research Collaboration with Schering-Plough
News

Codexis Enters into Research Collaboration with Schering-Plough

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Codexis Enters into Research Collaboration with Schering-Plough "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Codexis, Inc. has announced that it has signed a research agreement with Schering-Plough Corporation to develop a synthetic process for use by Schering-Plough

The collaboration will focus on improving biocatalyst productivity using Codexis' proprietary MolecularBreeding™ pharmaceutical process re-engineering platform.

Codexis will receive research funding and milestone payments upon completion of certain objectives of the research.

"We are pleased to add Schering-Plough to our list of industry-leading pharmaceutical partners," said Alan Shaw, Ph.D., Codexis President and Chief Executive Officer.

"We are delighted to see a growing number of major pharmaceutical companies recognizing the competitive advantage and cost-savings value that Codexis' technology brings to the manufacturing process for clinical-scale production and product commercialization, and look forward to continued adoption of our technology across the pharmaceutical industry."

Advertisement